N/A N=40 Medacta NextAR TKA Pivotal Trial
Musculoskeletal Diseases
Primary: Oxford Knee Score (OKS) — 39 scores on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=43 Promoting Resilience in Women With Breast Cancer
Breast Cancer
Primary: Feasibility of PRISM — 33; 10 Participants
N/A N=273 Video Discharge Instructions for Fever and ED Recidivism
Children Who Present to the ED With Minor Febrile Illnesses
Primary: Recidivism — 6; 3 number of return visits within 72 ho
N/A N=36 Brief Acceptance-Based Retention Intervention for Newly Diagnosed HIV Patients
HIV/AIDS
Primary: Number of Participants Meeting Retention in HIV Medical Care Guidelines at 52 Weeks — 20; 16 Participants
N/A N=80 Gynecologic Brachytherapy-Specific Educational Video
Cervical Cancer · Uterine Cancer
Primary: Patient Reported Satisfaction — 54; 55 satisfaction score at baseline
Phase 2 N=51 Treatment Combining Riluzole and IFB-088 in Bulbar Amyotrophic Lateral Sclerosis (TRIALS Protocol)
Amyotrophic Lateral Sclerosis · ALS
Primary: Safety Assessment of IFB-088 50 mg/Day in Patients With Bulbar-onset ALS. Number of Participants With Treatment-Emergent Adverse Events [Safety and Tolerability] — 10…
N/A N=110 Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer Survivors
Cancer-related Problem/Condition · Exercise · Acupressure
Primary: Change in Fatigue on the Patient-reported Outcomes Measure Information System (PROMIS-F) From Baseline to Week 12 (Post-intervention) — -3.8; -7.9; -5.8; -3.2 score on a…
N/A N=90 Comparing Pain, Safety and Effectiveness of Restylane Skinboosters Vital Lido and Vital Without Lido in Dorsal Hand
Skin Aging of Dorsal Hands
Primary: The Within-subject Difference in VAS Score (Restylane Skinboosters Vital Lidocaine- Restylane Vital) at End of Injection (T0). — 32.5; 46.9 score on a scale — p=<0.0001
N/A N=978 Health Education Model Led by Community Health Volunteers.
Schistosomiasis · Health Education
Primary: Change in Infection Rate — 47; 35; 3; 6 Number of Participants with S. haematobi
Phase 3 N=180 Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea
Glioblastoma
Primary: Progression-free Survival(PFS) — 5.4; 8.1 months
N/A N=20 Hepatic Mitochondrial Function in Youth
Hepatic Steatosis · Bariatric Surgery Candidate · Adolescent Obesity
Primary: Change in Percentage of Liver Fat Per MRI — -13.93 percentage of liver fat
Phase 4 N=150 The Role of Verapamil in Radial Artery Spasm
Radial Artery Spasm
Primary: Number of Participants With Clinical Radial Artery Spasm (RAS) — 23; 3 participants
N/A N=3 Home-based Transcranial Direct Current Stimulation (tDCS) for Behavioral Symptoms in Alzheimer's Disease and Related Dementias (ADRD)
Alzheimer Disease
Primary: Acceptability of the tDCS Treatment as Assessed by the tDCS Acceptability Questionnaire
Phase 4 N=124 A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures
Congenital Hemangioma · Hemangioendothelioma · Angiosarcoma
Primary: Adverse Drug Reactions During the Embolization Procedure — 0 Participants
N/A N=1,895 Implementing the Decision-Aid for Lupus (IDEAL Strategy)
Systemic Lupus Erythematosus
Primary: Penetration/Reach: Number of Eligible Participants at Each Clinical Site Who Enrolled Divided by the Number of Eligible Participants at Each Clinical Site, Expressed as…